A share price of Agios Pharmaceuticals Inc [AGIO] is currently trading at $51.59, up 10.47%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AGIO shares have gain 11.43% over the last week, with a monthly amount glided 27.38%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
On September 27, 2024, downgrade downgraded it’s rating to Market Perform and revised its price target to $56 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating. Piper Sandler initiated its recommendation with a Overweight and recommended $41 as its price target on February 03, 2023. Goldman upgraded its rating to Neutral for this stock on November 17, 2022, and upped its price target to $32. In a note dated July 27, 2022, SVB Leerink upgraded an Outperform rating on this stock but restated the target price of $33.
Agios Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $20.40 and $53.28. Currently, Wall Street analysts expect the stock to reach $48 within the next 12 months. Agios Pharmaceuticals Inc [NASDAQ: AGIO] shares were valued at $51.59 at the most recent close of the market. An investor can expect a potential drop of -6.96% based on the average AGIO price forecast.
Analyzing the AGIO fundamentals
Trailing Twelve Months sales for Agios Pharmaceuticals Inc [NASDAQ:AGIO] were 32.87M which represents 21.15% growth. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at -12.38%, Pretax Profit Margin comes in at 22.13%, and Net Profit Margin reading is 20.51%. To continue investigating profitability, this company’s Return on Assets is posted at 0.38, Equity is 0.7 and Total Capital is -0.24. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 49.05 points at the first support level, and at 46.50 for the second support level. However, for the 1st resistance point, the stock is sitting at 52.89, and for the 2nd resistance point, it is at 54.18.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Agios Pharmaceuticals Inc [NASDAQ:AGIO] is 8.99. As well, the Quick Ratio is 8.77, while the Cash Ratio is 2.12. Considering the valuation of this stock, the price to sales ratio is 89.51, the price to book ratio is 1.81 and price to earnings (TTM) ratio is 4.54.
Transactions by insiders
Recent insider trading involved Jones Cecilia, Chief Financial Officer, that happened on Sep 26 ’24 when 2542.0 shares were sold. Chief Executive Officer, Goff Brian completed a deal on Aug 08 ’24 to sell 11091.0 shares. Meanwhile, Officer Goff Brian bought 11091.0 shares on Aug 08 ’24.
